99 related articles for article (PubMed ID: 12355741)
1. [Uric acid metabolism and insulin resistance in type 2 diabetes].
Wasada T; Iwatani M
Nihon Rinsho; 2002 Aug; 60 Suppl 8():167-72. PubMed ID: 12355741
[No Abstract] [Full Text] [Related]
2. Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.
Stakos DA; Schuster DP; Sparks EA; Wooley CF; Osei K; Boudoulas H
J Cardiol; 2003 Apr; 41(4):183-90. PubMed ID: 12728539
[TBL] [Abstract][Full Text] [Related]
3. New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers.
Mudaliar S; Henry RR
Annu Rev Med; 2001; 52():239-57. PubMed ID: 11160777
[TBL] [Abstract][Full Text] [Related]
4. [Insulin sensitizer and urate metabolism].
Iwatani M; Wasada T; Iwamoto Y; Kamatani N
Nihon Rinsho; 2000 Feb; 58(2):430-4. PubMed ID: 10707571
[TBL] [Abstract][Full Text] [Related]
5. [Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].
Westerbacka J; Yki-Järvinen H
Duodecim; 1997; 113(19):1847-8. PubMed ID: 10892078
[No Abstract] [Full Text] [Related]
6. Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes.
Teter ML
Nurse Pract; 1997 Jul; 22(7):119-21. PubMed ID: 9253019
[No Abstract] [Full Text] [Related]
7. [Insulin sensitizer drugs--review].
Yamanouchi T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():409-15. PubMed ID: 12387026
[No Abstract] [Full Text] [Related]
8. Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes.
Sironi AM; Vichi S; Gastaldelli A; Pecori N; Anichini R; Foot E; Seghieri G; Ferrannini E
Clin Pharmacol Ther; 1997 Aug; 62(2):194-202. PubMed ID: 9284856
[TBL] [Abstract][Full Text] [Related]
9. [Hypoglycemic agents to improve insulin resistance].
Kadowaki T
Nihon Rinsho; 2000 Feb; 58(2):283-90. PubMed ID: 10847809
[No Abstract] [Full Text] [Related]
10. The role of troglitazone in treating the insulin resistance syndrome.
Granberry MC; Schneider EF; Fonseca VA
Pharmacotherapy; 1998; 18(5):973-87. PubMed ID: 9758309
[TBL] [Abstract][Full Text] [Related]
11. [Against insulin resistance. Insulin sensitizers].
Verspohl EJ; Weiland F
Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
[No Abstract] [Full Text] [Related]
12. Effects of troglitazone on insulin sensitivity.
Henry RR
Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone in type II diabetes mellitus.
Sparano N; Seaton TL
Pharmacotherapy; 1998; 18(3):539-48. PubMed ID: 9620105
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone for non-insulin-dependent diabetes mellitus.
Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
[No Abstract] [Full Text] [Related]
15. "Glitazones", a prospect for non-insulin-dependent diabetes.
Petrie J; Small M; Connell J
Lancet; 1997 Jan; 349(9045):70-1. PubMed ID: 8996411
[No Abstract] [Full Text] [Related]
16. The role of the thiazolidinediones in the practical management of patients with type 2 diabetes and cardiovascular risk factors.
Edelman SV
Rev Cardiovasc Med; 2003; 4 Suppl 6():S29-37. PubMed ID: 14668701
[TBL] [Abstract][Full Text] [Related]
17. [Rosiglitazone (BRL-49653)].
Oka Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():438-41. PubMed ID: 12387030
[No Abstract] [Full Text] [Related]
18. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
Caballero AE; Saouaf R; Lim SC; Hamdy O; Abou-Elenin K; O'Connor C; Logerfo FW; Horton ES; Veves A
Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
[TBL] [Abstract][Full Text] [Related]
19. [Glitazone--a new class of drugs for the treatment of type 2 diabetes].
Algenstaedt P; Hamann A
Dtsch Med Wochenschr; 2001 Aug; 126(34-35):951-2. PubMed ID: 11523019
[No Abstract] [Full Text] [Related]
20. New treatment for adult-onset diabetes.
Zurlinden J
Nurs Spectr (Wash D C); 1997 Aug; 7(16):8. PubMed ID: 9439332
[No Abstract] [Full Text] [Related]
[Next] [New Search]
